Conclusion
Therapeutic devices to treat epilepsy described in this review represent an incomplete list.
Some devices may come to the bedside and others will be found ineffective, too invasive or
too difficult to implement. Clinical trials of devices are more problematic than are
medication trials. Medical devices are expensive, although not necessarily more expensive
than chronic therapy with some drugs. Nevertheless, devices can provide clinically
meaningful benefits in people who have failed less invasive therapies. Devices are not
curative, and as such, device therapy will serve as an important bridge to the time when we
can prevent and cure epilepsy.